Australia Clinical Laboratory Tests Market Size & Outlook
- Clinical Diagnostics
- Laboratory Testing & Services
- Clinical Laboratory Tests Market Outlook
- Laboratory Testing & Services
Global Market
Related Markets
Ask a question about the clinical laboratory tests market
Australia clinical laboratory tests market highlights
- The Australia clinical laboratory tests market generated a revenue of USD 2,433.9 million in 2025 and is expected to reach USD 6,108.6 million by 2033.
- The Australia market is expected to grow at a CAGR of 12.2% from 2026 to 2033.
- In terms of segment, hba1c tests was the largest revenue generating type in 2025.
- HbA1c tests is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical laboratory tests market data book summary
| Market revenue in 2025 | USD 2,433.9 million |
| Market revenue in 2033 | USD 6,108.6 million |
| Growth rate | 12.2% (CAGR from 2026 to 2033) |
| Largest segment | Hba1c tests |
| Fastest growing segment | HbA1c tests |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Lipid panel tests, Renal panel tests, Liver panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global clinical laboratory tests market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China clinical laboratory tests market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,436.4 million by 2033.
The prevalence of diseases, such as diabetes and cardiovascular disorders, is growing in Australia. For instance, according to Baker Heart and Diabetes Institute, over 330,000 individuals in Australia are suffering from atrial fibrillation, and its prevalence can largely be attributed to diabetes. The prevalence of cancer is growing in the country.
Around 150,000 cancer cases were estimated to be diagnosed in 2020, and this number is expected to rise to 239,770 by 2030. Furthermore, in 2022, over 1.29 million people in the country had diabetes. In addition, one in four people living with diabetes remains undiagnosed.
Each year, over 500 million tests are delivered, which play a critical role in patient care and clinical decision-making. Routine tests account for 80% of the tests conducted in the country. In addition, the annual increase in patient burden on clinical laboratories is 5% to 10%. This is expected to increase the competition in the Australia market.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Clinical Reference Laboratory | View profile | 501-1000 | Lenexa, Kansas, United States, North America | www.crlcorp.com |
| OPKO Health Inc | View profile | 3,930 | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 | www.opko.com |
| ARUP Laboratories | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | www.aruplab.com |
| Sonic Healthcare Ltd | View profile | 41,000 | 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, Australia, 2000 | www.sonichealthcare.com |
| Cinven | View profile | 51-100 | London, England, United Kingdom, Europe | www.cinven.com |
| Unilabs | View profile | 1001-5000 | Geneva, Geneve, Switzerland, Europe | www.unilabs.com/ |
Australia Clinical Laboratory Tests Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Laboratory Tests Market Outlook will help companies and investors design strategic landscapes.
Hba1C Tests was the largest segment with a revenue share of 13.71% in 2025.
Horizon Databook has segmented the Australia clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, lipid panel tests, renal panel tests, liver panel tests covering the revenue growth of each sub-segment from 2021 to 2033.
The prevalence of diseases, such as diabetes and cardiovascular disorders, is growing in Australia. For instance, according to Baker Heart and Diabetes Institute, over 330,000 individuals in Australia are suffering from atrial fibrillation, and its prevalence can largely be attributed to diabetes. The prevalence of cancer is growing in the country.
Around 150,000 cancer cases were estimated to be diagnosed in 2020, and this number is expected to rise to 239,770 by 2030. Furthermore, in 2022, over 1.29 million people in the country had diabetes. In addition, one in four people living with diabetes remains undiagnosed.
Each year, over 500 million tests are delivered, which play a critical role in patient care and clinical decision-making. Routine tests account for 80% of the tests conducted in the country. In addition, the annual increase in patient burden on clinical laboratories is 5% to 10%. This is expected to increase the competition in the Australia market.
- Australia Clinical Laboratory Tests Market Type Outlook (Revenue, USD Million , 2021-2033)
- Complete blood count
- HGB/HCT tests
- Basic metabolic panel
- BUN creatinine tests
- Electrolytes testing
- HbA1c tests
- Comprehensive metabolic panel tests
- Liver panel tests
- Renal panel tests
- Lipid panel tests
- Others
- Australia Clinical Laboratory Tests Market End-use Outlook (Revenue, USD Million , 2021-2033)
- Primary Clinics
- Central Laboratories
Reasons to subscribe to Clinical Laboratory Tests Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Laboratory Tests Market Outlook databook
- Our clientele includes a mix of Clinical Laboratory Tests Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Clinical Laboratory Tests Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Clinical Laboratory Tests Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Clinical Laboratory Tests Market, 2021-2033 (US$M)
Australia clinical laboratory tests market statistics, by type, 2021-2033 (US$M)
